Cell/Gene Tx channel feed – Endpoints News

Cell/Gene Tx channel feed

In a leaked abstract, J&J's cell therapy appears to have dramatic benefits for multiple myeloma patients

3 years ago

VCs 'Complement' European biotech with $79M for retinal AAV gene therapy trial next year

3 years ago

At $2M per shot, ICER says two new sickle cell gene therapies could be cost-effective

3 years ago

Takeda taking magnifying glass to non-viral gene therapy programs as Carmine pact ends

3 years ago

Novo Nordisk taps into Canadian biotech’s cell therapies for diabetes and obesity in deal worth up to $2.6B

3 years ago

Exclusive: Cell and gene therapy CDMO VintaBio emerges onto the scene with $64M and a new CEO

3 years ago

A new cell therapy biotech emerges to find solid tumor-killing immune cells in patients' blood

3 years ago

Sartorius to acquire French manufacturer for $2.6B+ in cell and gene therapy play

3 years ago

Nanoscope’s eye disease gene therapy shows mixed results in PhII

3 years ago

Athenex discloses patient death, clinical hold on CAR-NKT trial as it seeks strategic alternatives

3 years ago

Novartis and Biogen pull out of neuro drug partnerships with Sangamo

3 years ago

In reversal, Sarepta to face FDA’s panel of outside experts on Duchenne gene therapy

3 years ago

Seagen quietly doles out cell therapy patent rights, but scope remains unclear

3 years ago

German biotech launches with ‘seamless’ gene editing platform built on evolving enzymes

3 years ago

Sigilon focuses on type 1 diabetes, reduces spend on MPS-1 after letting CMO go (corrected)

3 years ago

Flagship biotech 'Rings' in $85M+ for next-gen gene therapy effort

3 years ago

Biotech pain continues as Versant, MPM gene therapy startup calls it quits

3 years ago

FDA delays review of BioMarin's hemophilia gene therapy after data update

3 years ago

French CAR-T biotech Mnemo Therapeutics shutters US operations

3 years ago

Months after reorg, Adaptimmune merges with fellow cell therapy developer

3 years ago

Voyager nabs $25M cash as Novartis runs with two AAV capsids for neuro gene therapy

3 years ago

Ex-AveXis crew trims staff at Chicago-area Jaguar Gene Therapy

3 years ago

Cell therapy biotech from Stanford CAR-T leader Crystal Mackall nabs $200M for PhII

3 years ago

Sarepta won't need FDA adcomm, boosting Duchenne gene therapy's odds

3 years ago

First page Previous page 20 21 222324 25 26 Next page Last page